On Tuesday, December 3, 2019, Brazil’s pharmaceutical regulator Avinsa approved regulations for the roll-out of medicinal cannabis-based products.
November 20, 2019 marked a monumental day in the prohibition of cannabis. The House Judiciary Committee (1) approved a bill that would federally decriminalize cannabis by removing it from the Controlled Substance Act and expunge particular crimes related to marijuana.
From 9/11 First Responder to Cancer Survivor and Cannabis Entrepreneur: How One Man’s Cannabis Journey Is Impacting the Medicinal Field
Aryn Sieber, the founder and CEO of CBD Essentials and Cannaisseur Brands as well as the founder of CannaCauses Foundation, discusses his experiences as a 9/11 first responder, his battle with stage IV cancer, and how cannabis impacted his life.
Dr. Andrea Holmes discusses how she’s using colorimetric analysis to discover novel minor cannabinoids, the potential role of smartphone compatibility in detection, what’s next for cannabinoid research, and more.